Tagged with J

Japan Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park explores new ways of virtual collaboration that make our lives easier while enabling us to maintain a culture of innovation and growth.   Are social distancing requirements causing the life science industry to return to an inward-looking culture of secrecy?…

Japan Yoji Yuki, CEO of Japanese regenerative medicine company UniBio, recalls the roots behind the venture and its plant-based technology. He also sets out his ambitions to expand and develop greater manufacturing capabilities in order to meet UniBio’s future ambitions.   What is most important to stress is that there are…

Precision Medicine With Asia covering 60 percent of the world’s population but accounting for just around 30 percent of global pharma spending, it goes without saying that healthcare needs in the region must be addressed effectively, quickly and comprehensively. Who better to accomplish that than the Asian companies on the ground, closest…

Medtech Saudi Arabia is seeing an increased demand for more innovative medical devices and a greater awareness of the myriad ways that medical technology can be used for screening illnesses such as cardiovascular disease, cancer and diabetes. Stakeholders from three multinational medtech firms commented on their strategies for growth in this…

Korea Korean biosimilar firm Celltrion’s USD 266 million acquisition of Japanese outfit Takeda assets in the Asia-Pacific region marks a significant moment in Celltrion’s international expansion as well as yet another big-money deal for Takeda.   Since Takeda’s earthshattering announcement of its intended USD 62 billion acquisition of Shire – the…

Japan Japan’s pharma market is one of the world’s biggest, with a value of around USD 95 billion, according to figures from the country’s Ministry of Health, Labour and Welfare (MHLW). Japanese firms have a particularly strong standing in their home market, making up six of the country’s top ten pharma…

China Johnson & Johnson’s network of healthcare innovation incubators, JLABS, opened its doors in Shanghai in June 2019 and now stands as the largest such institution of 13 globally. JLABS @ Shanghai’s head, Dr Sharon Chan, recently sat down with PharmaBoardroom to explain the JLABS model, how it has had to…

Coronavirus During the 28 May 2020 IFPMA media briefing on COVID-19 vaccines, four of the pharmaceutical industry’s leading executives discussed where their firms are in the race to find a vaccine, the unprecedented levels of speed and collaboration being seen, and the challenges that lie ahead. Here we present five of…

China Dr Sharon Chan, head of JLABS @ Shanghai – the first JLABS presence in Asia-Pacific as well as the largest globally – shares how Johnson & Johnson is investing in the innovation ecosystem in China and the APAC region; some of the key milestones over the past year; and her…

Talent Four Belgium country managers for some of the world’s largest pharma companies give their words of wisdom for women starting out in the industry.   “Focus on your strengths” Sonja Willems, managing director for Janssen in Belgium, the Netherlands, and Luxembourg (Benelux) shares her wisdom for people building their careers…

Cell & Gene Therapy A full list of the regenerative medicine products that have been approved by the PMDA, Japan’s drug regulatory body.   Made with Visme Infographic Maker  

Japan A comprehensive list of the new drugs approved by Japan’s Pharmaceutical and Medical Devices Agency (PMDA) in 2019. Made with Visme Infographic Maker